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Background/Aims: The endoscopic step-up approach is accepted as the preferred treatment for 
complicated or symptomatic walled-off necrosis (WON). Direct endoscopic necrosectomy (DEN) 
is an effective therapeutic option, but few reports describe long-term follow-up in this patient 
population. Thus, we aim to assess the long-term outcomes of DEN following severe necrotizing 
pancreatitis.
Methods: The data of all acute pancreatitis patients who underwent DEN following endoscopic 
transmural drainage from six referral centers between 2007 and 2017 were retrospectively col-
lected.
Results: Sixty patients (76.7% male, mean age 48.3 years) underwent a median of 4 sessions 
of DEN starting at a median of 45.5 days after the onset of acute pancreatitis. Clinical success 
was achieved in 51 patients (85%), with a 35% complication rate and a 5% mortality rate. Using 
multivariate analysis, the risk factor associated with DEN failure or major DEN complications 
requiring intervention or surgery was an identified bacterial/fungal WON infection (odds ratio, 
19.3; 95% confidence interval, 1.5 to 261.7). During the median follow-up period of 27 months, 
complicated WON recurrence was observed in 5.3% of patients, and long-term complications oc-
curred in 24.6% of patients (four exocrine insufficiency, nine newly developed diabetes mellitus, 
one recurrent small bowel obstruction, one chylous ascites).
Conclusions: Considering that long-term complications are similar to those observed after pan-
createctomy, DEN should be performed meticulously while minimizing damage to the viable pan-
creatic parenchyma with adequate antibiotic escalation. (Gut Liver 2021;15:930-939)
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INTRODUCTION
Acute necrotizing pancreatitis is a potentially lethal 
disease, and its incidence is currently increasing. Because 
infected necrotizing pancreatitis is associated with a mor-
tality of 20% to 30%, an expert multidisciplinary team 
approach is required to improve clinical outcomes.1-5 Over 
the past decade, much progress has been made in improv-
ing the management of acute necrotizing pancreatitis.6,7 
A surgical step-up approach consisting of percutaneous 
catheter drainage followed by minimally invasive surgi-
cal necrosectomy has replaced open necrosectomy as the 
standard treatment.8-10 Endoscopic treatment has also been 
highlighted because it is potentially less invasive and can 
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also be performed in a step-up manner.11-13 Endoscopic 
transmural drainage (ETD) is usually the first procedure to 
be performed, followed up by direct endoscopic necrosec-
tomy (DEN) if required for improving clinical outcomes. 
In a Dutch randomized trial, the risk of developing a pan-
creatic fistula and the length of hospital stay were lower 
in the endoscopy group when compared to the surgical 
group. However, endoscopy did not demonstrate superior 
therapeutic outcomes in terms of mortality and major 
complications.14 Contrary to these data, a U.S. randomized 
trial indicated that an endoscopic transluminal approach 
reduced major complications, lowered costs, and increased 
the patients’ quality-of-life when compared to minimally 
invasive surgery.15,16 Controversy remains as to whether an 
endoscopic step-up approach should be used as the pre-
ferred therapeutic modality for infected necrotizing pancre-
atitis. Furthermore, sufficient information from long-term 
follow-up after DEN does not currently exist. Therefore, we 
aimed to assess the long-term outcomes of DEN following 
ETD as part of an endoscopic step-up approach in patients 
with severe acute necrotizing pancreatitis.
MATERIALS AND METHODS
1. Patient information
The Korean Pancreatobiliary Association conducted a 
nationwide multicenter retrospective study by accumulat-
ing information on severe acute necrotizing pancreatitis 
patients who underwent DEN across six referral centers 
in Korea between January 2007 and December 2017. After 
standardized data collection forms were sent to each cen-
ter, each institution retrospectively reviewed their database 
and collected the clinical data. The participating institu-
tions were Asan Medical Center (Seoul), Gachon Universi-
ty Gil Medical Center (Incheon), Hallym University Dong-
tan Sacred Heart Hospital (Hwaseong), Hallym University 
Sacred Heart Hospital (Anyang), Inha University hospital 
(Incheon), and Soonchunhyang University Bucheon Hos-
pital (Bucheon) in the Republic of Korea. Institutional 
review board approval was obtained for each participant in 
this study. The informed consent was waived. A total of 60 
patients were ultimately included in this study. 
2. Procedures
The indications for endoscopic intervention were de-
termined for each patient. Inclusion criteria were symp-
tomatic or complicated walled-off necrosis (WON), such 
as suspected/identified infection, and biliary/gastric outlet 
obstruction following severe necrotizing pancreatitis. The 
standard technique used for the endoscopic step-up ap-
proach is described as follows. Endoscopic ultrasound-
guided transmural drainage was performed using either 
one or two 7-F double-pigtail plastic stents (DPPS) or 
self-expandable metallic stent (SEMS). Based on clinical 
decisions, an additional nasocystic drainage catheter was 
placed into the WON cavity if necessary. Types of SEMS 
used were as follows: tubular fully covered SEMS including 
26 Soo stents (Standard Sci Tech Inc., Seoul, Korea), seven 
AL stents (Standard Sci Tech Inc.) and two Nagi stents 
(Taewoong Medical, Goyang, Korea), or lumen-apposing 
metallic stent of six SPAXUS stents (Taewoong Medical). If 
there was no clinical improvement following ETD, a DEN 
was performed. In most cases, an established fistula tract 
was dilated using a large balloon (maximal diameter, 12 to 
20 mm) several days after placement of stent or drainage 
catheter. A conventional forward-viewing endoscope or 
water jet scope (GIF-Q260J; Olympus, Tokyo, Japan) was 
subsequently advanced into the WON cavity and mechani-
cal debridement of the necrotic tissue was performed using 
snares, forceps, and stone removal baskets accompanied by 
forceful irrigation using normal saline. In anticipation of a 
subsequent DEN, the fistula to the necrotic cavity is main-
tained by placing a DPPS or nasocystic drainage catheter. 
Repeated DEN sessions were carried out until clinical im-
provement was achieved, regardless of whether the necrot-
ic debris in the WON was completely removed. At the final 
DEN session, a DPPS might be placed depending on each 
institution’s protocol. Depending on the patient’s condition, 
additional intervention measures, including transpapil-
lary pancreatic duct (PD) stenting, percutaneous drainage, 
and surgery were performed as necessary. Additionally, in 
order to diagnose WON infection, microbial culture was 
conducted with pus aspirated in the ETD procedure. If the 
patient's condition did not improve, additional culture tests 
were performed in pus and necrotic tissue during DEN.
3. Outcomes
The primary outcome was to assess the long-term clini-
cal outcomes, such as recurrence of the symptomatic/
complicated WON and late complications following DEN. 
The definition of symptomatic/complicated WON is as fol-
lows: (1) clinical suspicion or documented infected WON 
with clinical deterioration; (2) symptomatic sterile WON 
including intractable pain, persistent unwellness, ongoing 
gastrointestinal obstruction despite medical treatment; 
(3) abdominal compartment syndrome or disconnected 
PD syndrome with WON. In terms of long-term results, 
the recurrence of WON was defined as the case of WON 
redevelopment after 6 months of last DEN session in a 
patient who had completed treatment. New onset diabetes 
mellitus was defined as requiring insulin or oral antidia-
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betic drugs for at least 6 months after DEN and not present 
prior to the onset of pancreatitis. Exocrine insufficiency 
was defined as the development of clinical symptoms of 
steatorrhea and weight loss in patients not previously tak-
ing oral pancreatic enzyme supplements. The secondary 
outcomes were to evaluate the initial treatment success and 
early complication rates associated with DEN. Clinical suc-
cess of the DEN was defined as improvement of WON on 
computed tomography (CT) scan in association with clini-
cal resolution of symptoms at 6-month follow-up period.17 
DEN failure was defined as the need for rescue surgery or 
death during index admission as well as readmission for 
management of recurred pancreatitis or WON within 6 
months. 
Other DEN-related complications are defined as fol-
lows; “massive bleeding” is the bleeding within the intraab-
dominal cavity or gastrointestinal tract requiring radio-
logic interventional procedure, “visceral perforation” is the 
perforation of visceral organ with intraabdominal free air, 
“duodenal or colonic fistula” is the formation of a fistula 
between the small bowel or colon and pancreas confirmed 
on imaging or endoscopy.
4. Statistical analysis
Differences of continuous variables were compared 
using the independent t-tests. Categorical variables were 
compared by the chi-square tests or Fisher exact test. 
Multivariate logistic regression analysis was performed 
to evaluate the independent effect of each variable. Odds 
ratios and confidence intervals were calculated. Statistical 
analysis was performed using the SPSS software, version 
24.0 for Windows (IBM Corp., Armonk, NY, USA). Statis-
tical significance was reached when p-values were below 
0.05.
RESULTS
1. Characteristics of patients
A total of 60 patients (76.7% male, mean age 48.3 years) 
with complicated or symptomatic WON were included 
from six centers. Twenty of the total 60 patients were treat-
ed in the intensive care unit. Continuous renal replace-
ment therapy was administered in 10 patients, and one 
patient improved after receiving extracorporeal membrane 
oxygenation. The main causes underlying acute pancreati-
tis in these patients were alcohol (45%) and the presence 
of gallstones (25%). The size of the WON (mean of long 
axis×short axis) was estimated to be 145.9×72.1 mm and 
the median severity index determined by CT was 6. Coro-
nal CT imaging was used to evaluate the lower margin 
of the WON, which was found to be an extension to the 
pelvic cavity in 15 patients and below the kidney in 34 pa-
tients. Twenty-one patients had undergone percutaneous 
catheter drainage. Additionally, the medians of laboratory 
findings in these patients at the time of DEN were as fol-
Table 1. Characteristics of Patients with Complicated or Symptomatic 




    Male 46 (76.7)





    Alcohol 27 (45.0)
    Gallstone 15 (25.0)
    Post-ERCP 6 (10.0)
    Others* 12 (20.0)
Diabetes mellitus
    Yes 12 (20.0)
    No 48 (80.0)
Initial management of pancreatitis
    ICU care 20 (33.3)
    CRRT/ECMO 10 (16.7)/1 (1.7)
CT severity index score 6 (5–7)
Previous placement of PCD 21 (35.0)
Main locations of WON 
    Head 7 (11.7)
    Body and tail 32 (53.3)
    Entire pancreas 21 (35.0)
Lower margin of WON cavity
    Above kidney/below kidney   11 (18.3)/34 (56.7)
    Extension to pelvic cavity 15 (25.0)
No. of WON cavities
    Single 28 (46.7)
    Multiple 32 (53.3)
Size, mm
    Long axis 145.9±50.6
    Short axis 72.1±33.1
Laboratory findings at the time of DEN
    White blood cell, /mm3 16,380 (13,047–20,005)
    CRP, mg/dL 10.6 (0.4–30.7)
    Amylase, U/L 438 (146–2,667)
    Lipase, U/L  938 (106–10,886)
    Creatinine, mg/dL 1.03 (0.71–1.57)
Data are presented as mean±SD, number (%), or median (interquartile 
range).
BMI, body mass index; ERCP, endoscopic retrograde cholangio-
pancreatography; ICU, intensive care unit; CRRT, continuous renal 
replacement therapy; ECMO, extracorporeal membrane oxygenation; 
CT, computed tomography; PCD, percutaneous catheter drainage; 
WON, walled-off necrosis; DEN, direct endoscopic necrosectomy; 
CRP, C-reactive protein.
*Others include hypertriglyceridemia-induced, malignancy, postop-
erative, and trauma.
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lows: white blood cell counts 16,380/mm3, amylase 438 U/
L, lipase 938 U/L, creatinine 1.03 mg/dL, and C-reactive 
protein 10.6 mg/dL (Table 1). 
2. Initial outcomes of DEN
Initial ETD using DPPS or SEMS were performed after 
a median duration of 34 days (interquartile range [IQR], 
21 to 52.5 days) from the onset of pancreatitis. Of them, 
transmural SEMS placement was achieved in 41 patients 
(68.3%). If the patient’s condition did not improve even 
during ETD, DEN was administered after a median dura-
tion of 45.5 days (IQR, 31.25 to 70.75 days) after the index 
admission. Indication of DEN were as follows; suspected 
infection (fever and pain) in 40 patients, intractable pain in 
Table 2. Procedural Details and Outcomes of Direct Endoscopic Necrosectomy
Direct endoscopic necrosectomy Value
Time from onset of pancreatitis to initial EUS drainage, day 34 (21.0–52.5)
Placed drainage method
    DPPS and/or nasocystic drainage catheter 19 (31.7)
    SEMS and/or nasocystic drainage catheter 41 (68.3)
Time from onset of pancreatitis to the first DEN, day 45.5 (31.25–70.75)
Indications of DEN
    Suspected infection 40 (66.7)
    Intractable pain 18 (30.0)
    Gastric outlet obstruction 2 (3.3)
Diameter of dilation for entry site of DEN, mm
    12–15 35 (58.3)
    16–20 25 (41.7)
Route
    Transgastric 53 (88.3)
    Transduodenal 5 (8.3)
    Both 2 (3.3)
Gateway
    Single 49 (81.7)
    Multiple 11 (18.3)
No. of DEN 4 (2–6)
Procedural time of DEN in each session, min 48 (37.25–64.23)
Insufflation during the procedure
    Room air 6 (10.0)
    CO2 gas 54 (90.0)
ERCP 27 (45.0)
    Identified main PD disruption 15 (25.0)
    Transpapillary PD stent 17 (28.3)
Preprocedural intravenous antibiotics 60 (100)
Identified infection in WON cavity
    Yes 44 (73.3)
    No 16 (26.7)
Clinical outcomes of DEN as part of endoscopic step-up approach
    Success 51 (85.0)
    Failure
        Surgery/pancreatitis-related mortality* 6 (10.0)/3 (5.0)
        WON recurrence within 6 months 4 (6.7) 
Degree of cavity clearance at the end of DEN
    Complete clearance 8 (13.3)
    Incomplete clearance 52 (86.7)
Procedure related complications during the treatment period of DEN 21 (35.0)
    Massive bleeding requiring radiologic intervention 9 (15.0)
    Visceral perforation 3 (5.0)
    Stent migration 8 (13.3)
    Duodenal or colonic fistula 5 (8.3)
    Others† 2 (3.3)
Data are presented as median (interquartile range) or number (%).
EUS, endoscopic ultrasound; DPPS, double-pigtail plastic stents; SEMS, self-expandable metallic stent; DEN, direct endoscopic necrosectomy; 
CO2, carbon dioxide; ERCP, endoscopic retrograde cholangiopancreatography; PD, pancreatic duct; WON, walled-off necrosis.
*Two cases of mortality developed despite surgical intervention; †Others include air embolism, cutaneous fistula.
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18 patients, and gastric outlet obstruction in two patients. 
With respect to the DEN technique, transgastric (53 cases), 
transduodenal (five cases), or both (two cases) routes were 
used, and the multiple gateway technique was performed 
in 11 patients (18.3%). Carbon dioxide (CO2) gas was used 
instead of room air for insufflation in 54 patients (90%). A 
median of 4 necrosectomy sessions (IQR, 2 to 6 sessions) 
was carried out and the median procedural time of each 
session was estimated to be 48 minutes (IQR, 37.25 to 
64.23 minutes). Endoscopic retrograde cholangiopancrea-
tography was performed in 27 patients and was followed 
by PD stenting in 17 patients (28.3%). WON infection 
was identified in 44 patients (73.3%) (Table 2). In terms of 
short-term outcomes, clinical success was achieved in 51 
patients (85%) and DEN complications developed in 21 
patients (35%). Among them, major complications such as 
bleeding requiring intervention (n=9), perforation requir-
ing surgery (n=1), and air embolism (n=1) developed in 10 
patients (16.7%). The WON recurrence was developed in 
four patients within 6 months after discharge, that might be 
attributed to unsuccessful DENs. Additionally, six patients 
underwent surgery and three patients succumbed to pan-
creatitis-related mortality (Fig. 1). Altogether, there were 
16 patients (26.7%) who displayed DEN failure or major 
complications associated with DEN. Multivariate analysis 
demonstrated that the only significant risk factor for those 
patients was an identified bacterial/fungal infection of the 
WON (odds ratio, 19.28; 95% confidence interval, 1.50 to 
261.7) (Table 3). Among 44 patients with positive microbial 
cultures, Candida infection was found in six patients and 
bacterial infection was noted in 41 patients. The bacterial 
infections included carbapenem-resistant Acinetobacter 
baumannii that was identified in five patients, carbapenem-
resistant Klebsiella pneumoniae in one patient, extended-
spectrum beta-lactamase-producing Klebsiella pneumonia 
in one patient, methicillin-resistant Staphylococcus aureus 
in 11 patients, and vancomycin-resistant enterococci in two 
patients; infection with multidrug-resistant bacteria was 
found in 17 (28.3%) of 60 patients (Table 4). Furthermore, 
at the end of the DEN procedure, complete clearance of 
necrotic tissue in the WON cavity under visualization of 
DEN was achieved in eight patients (13.3%) (Fig. 2).
Fig. 1. Flowchart showing the treatment courses of the study patients.
WON, walled-off necrosis; DEN, direct endoscopic necrosectomy; PCD, percutaneous catheter drainage; FU, follow-up. *Air embolism and bleed-
ing occurred simultaneously in one patient.
Complicated/symptomatic WON (n=60)
Step up approach: DEN (n=60) combined with PCD (n=21)
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3. Long-term follow-up after DEN
Complete follow-up data were obtained for 57 patients, 
after excluding patients that displayed early mortality in the 
study group. The median follow-up period was 27 months 
(IQR, 7.8 to 48.4 months). The recurrence of symptomatic/
complicated WON was observed in three patients (5.3%) 
after 6 months of last session of DEN, and the median time 
to recurrence after completion of DEN was 193 days, 375 
days and 433 days (Fig. 1). The cause of recurrence was 
alcohol in one and unknown in two patients. Long-term 
complications occurred in 14 patients (24.6%) and in-
cluded four cases of pancreatic exocrine insufficiency, nine 
cases of newly developed diabetes mellitus, one case of 
recurrent small bowel obstruction, and one case of chylous 
ascites (Table 5). Moreover, when the long-term outcomes 
and recurrences were compared according to the degree 
of DEN, there is no difference of those between visual es-
timation of complete and incomplete clearance of necrotic 
tissue in WON cavity at end session of DEN (p<0.99) (Table 
6). In addition, three patients died due to causes unrelated 
to the DEN or pancreatitis: one succumbed to lung can-
cer after 63 months, one to alcoholic ketoacidosis after 26 
months, and another patient died due to pancreatic cancer 
after 16 months.
DISCUSSION
With the evolution of endotherapy in recent years, 
endoscopic step-up approaches have gained popularity 
for the treatment of complicated or symptomatic WON. 
Various methods have been suggested, including step-up 
approaches in which DPPS or metal stents (e.g., tubular 
SEMS or lumen-apposing metallic stent) are placed to 
Table 4. Type and Frequency of Grown Organisms in Positive Aspirate/
Tissue Cultures
Variable Isolates, No. (%)
Total patients (monomicrobial/polymicrobial infection) 44 (35/9)
Total microorganisms 64
    Gram negative
    Klebsiella pneumoniae 6 (9.4)
    Pseudomonas aeruginosa 2 (3.1)
       Enterobacter aerogenes 5 (7.8)
       Escherichia coli 1 (1.6)
       Acinetobacter baumannii 9 (14.1)
       Citrobacter species 2 (3.1)
       Aeromonas hydrophilia 1 (1.6)
       Stenotrophomonas maltophilia 6 (9.4)
       Morganella morganii 1 (1.6)
    Gram positive
       Enterococci species 7 (10.9)
       Staphylococcus aureus 15 (23.4)
       Coagulase-negative Staphylococci 2 (3.1)
       Streptococcus species 1 (1.6)
    Fungus
       Candida albicans 5 (7.8)
       Candida glabrata 1 (1.6)
Multidrug-resistant bacteria 20
    ESBL-producing Klebsiella pneumoniae 1 (5.0)
    Carbapenem-resistant Klebsiella pneumoniae 1 (5.0)
    Carbapenem-resistant Acinetobacter baumannii 5 (7.8)
    Methicillin-resistant Staphylococcus aureus 11 (55.0)
    Vancomycin-resistant enterococci 2 (10.0)
ESBL, extended spectrum-beta lactamase.
Table 3. Risk Factors Associated with the Clinical Outcomes of Direct Endoscopic Necrosectomy
Risk factor
DEN failure* or with major 
complications† (n=16)
Successful DEN (n=44) p-value‡ OR (95% CI) p-value§
Age, mean±SD, yr 43.9±14.2 49.8±14.6 0.016 0.99 (0.94–1.04) 0.679
Sex (male/female) 14/2 32/12 0.314
BMI, mean±SD, kg/m2 24.8±2.8 24.2±4.0 0.564
Identified WON infection (yes/no) 15/1 29/15 0.046  19.28 (1.50–261.70) 0.023
CRRT (yes/no) 10/6 4/40 0.017 2.00 (0.33–12.0) 0.449
Additional PCD (yes/no) 9/7 12/32 0.064 3.30 (0.71–15.34) 0.128
Initial drainage method  
(plastic/metal stent)
3/13 16/28 0.228
Gateway (single/multiple) 12/4 37/7 0.462
Transpapillary PD stent (yes/no) 2/14 15/29 0.120 0.22 (0.35–1.35) 0.218
Pelvic extension of necrotic cavity 
(yes/no)
7/9 8/36 0.088 3.17 (0.51–19.74) 0.315
No. of cavity (multiple/single) 11/5 21/23 0.242
Largest diameter of necrotic cavity 
(≥15 cm/<15 cm)
5/11 27/27 0.764
DEN, direct endoscopic necrosectomy; OR, odds ratio; CI, confidence interval; BMI, body mass index; WON, walled-off necrosis; CRRT, continuous 
renal replacement therapy; PCD, percutaneous catheter drainage; PD, pancreatic duct.
*Rescue surgery or death during index admission, readmission within 6 months; †Massive bleeding or perforation requiring radiological/surgical 
intervention or air embolism; ‡Univariate analysis; §Multivariate analysis.
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drain the fluids and then if necessary, the remaining ne-
crosis is removed by DEN. In general, the indications for 
intervention in the WON are as follows: (1) clinical suspi-
cion or identified infection of the WON with clinical de-
terioration; (2) ongoing organ failure in the several weeks 
following onset of acute pancreatitis; (3) symptomatic ster-
ile WON including intractable pain, persistent discomfort, 
and ongoing gastrointestinal and biliary obstruction; or 
(4) disconnected PD syndrome.18 In this study, the major 
indication resulting in DEN is suspected infection of the 
WON in 40 patients (66.7%). However, 44 patients (73%) 
who underwent DEN had bacterial or fungal infection. In 
the 15 patients who reported intractable pain and the one 
patient with gastric outlet obstruction, infections were also 
identified. Additionally, of the 40 patients with suspected 
infections, pathogens were not confirmed in 12 patients. 
This is believed to result from preprocedural antibiotic 
use prior to the endoscopic treatment (Table 2). Currently, 
much debate surrounds the routine use of antibiotics in 
severe necrotizing pancreatitis, however antibiotic escala-
tion could be beneficial for those requiring DEN because 
our study indicated that identified infection was the only 
significant risk factor associated with DEN failure and 
major complications. Furthermore, considering the high 
incidence of multidrug-resistant infection, appropriate 
antimicrobial therapy should be chosen in accordance 
with results from sensitive pathogen identifying tests.19 We 
expect that this approach will result in a better DEN out-
come. 
Furthermore, we investigated whether long-term re-
currence or complications may occur following DEN. 
Although long-term follow-up results were inadequate 
in previous studies, the 6-month follow-up data from the 
MISER trial15 suggested that new onset diabetes developed 
in six patients (27.3%) and pancreatic insufficiency was 
diagnosed in 29 patients (85.3%) following the endoscopic 
step-up approach for necrotizing pancreatitis. In the long-
term follow-up data from the PANTER trial,10 which 
compared minimal versus open surgical necrosectomy, the 
step-up group had a lower proportion of incisional hernias 
(23% vs 53%), pancreatic exocrine insufficiency (29% vs 
56%), and endocrine insufficiency (40% vs 64%) after a 
mean follow-up of 86 months following discharge after the 
index admission. Additionally, the GEPARD study20 ob-
served that the DEN group had overall long-term clinical 
success in 84% of the patients. WON recurrence developed 
in 11% of the patients and new onset diabetes was diag-
nosed in 20% of the patients after a mean follow-up period 
of 43 months. In the present study, symptomatic/compli-
cated WON recurrence was confirmed in 5.3% of the pa-
tients and long-term complications developed in 22.8% of 
the patients after a median follow-up period of 27 months. 
Specifically, new onset diabetes and exocrine insufficiency 
developed in 15.8% and 7.0% of the patients, respectively. 
This was comparable to the results of GEPARD study. In-
terestingly, we found DEN-related typical long-term com-
plications of chylous ascites and intestinal obstruction that 
may have occurred during pancreatic surgery. Thus, it is 
necessary to take measures to minimize damage of viable 
Table 5. Long-term Follow-up of 57 Patients after Direct Endoscopic 
Necrosectomy
Outcome Value
FU duration after completion of endoscopic necro-
sectomy, median (IQR), mo
27 (7.8–48.4)
Recurrence of complicated/symptomatic WON, No. (%) 3 (5.3)
Recurrence time after completion of endoscopic 
necrosectomy, median (range), day
378 (193–433)
Long-term complication, No. (%) 14 (24.6)
    Pancreatic exocrine insufficiency 4 (7.0)
    Newly developed DM 9 (15.8)
    Others* 2 (3.5)
Death, No. (%)† 3 (5.3)
FU, follow-up; IQR interquartile range; WON, walled-off necrosis; DM, 
diabetes mellitus.
*Others include chylous ascites and recurrent small bowel obstruc-
tion; †Alcoholic ketoacidosis, pancreatic cancer, and lung cancer.
A B
Fig. 2. Intracavitary image of a walled- 
off necrosis with (A) complete or (B) 
incomplete removal of necrotic debris 
in the last session of direct endoscopic 
necrosectomy.
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pancreatic tissue as much as possible during DEN.
Multiple methods have been used to increase the ef-
fectiveness of necrosectomy, but many questions remain 
surrounding the uncertainty of optimal timing, number of 
sessions, interval between sessions, and the degree of com-
pleteness of DEN.1,6,21,22 To date, the endpoint of DEN has 
not been definitively established. These decisions should 
be based on patient’s clinical course, the indication for in-
tervention and endoscopist expertise and preference. Asian 
consensus statement suggested that the clearance of ne-
crotic debris and pink granulation tissue lining the wall in 
the WON cavity were important parameters of successful 
DEN.23 However, it is also unclear whether necrosectomy 
should be carried out for complete debridement of necrotic 
tissue within the WON in every case because complete 
debridement may itself result in extensive injury of vi-
able pancreatic parenchyma and possible damage to sur-
rounding hidden blood vessels. If the patient's symptoms 
improve, it may be helpful to treat the underlying infection 
while maintaining transmural DPPS drainage without 
completely elimination of the necrotic tissues. In this study, 
complete clearance of necrotic debris in the WON cavity at 
the last session of DEN was only achieved in eight patients 
(13.3%) under direct visualization. If the clinical resolution 
was achieved by a combination of appropriate antibiotic 
escalation with repeated DENs, the degree of necrotic tis-
sue clearance in the WON at the last DEN session had no 
significant effects on symptomatic/complicated WON re-
currence and long-term complications. In order to obtain 
better clinical outcomes, it is therefore recommended not 
only to perform microbial culture of both aspirated pus 
and necrotic tissue, but also to minimize unnecessary pan-
creatic injury during DEN.
There are several limitations to this study. First, the 
retrospective design and limited sample size have inherent 
limitations. This study was designed as a multicenter study 
to overcome size limitations, but each institution lacked 
consensus for the indication, timing, and DEN methods 
used. Furthermore, it would be ideal to have specific tech-
niques and procedural elements for a successful DEN, but 
since various methods are used and inconsistent in almost 
all procedural details, a unified procedural technique can-
not be presented. For instance, consensus has not been 
reached regarding the effectiveness of hydroperoxide or 
antibiotics lavage, access technique, amount of debride-
ment, benefit of saline irrigation via nasobiliary tube, and 
use of preprocedural antibiotics or proton pump inhibi-
tor during DEN. Secondly, for the evaluation of long-
term complications, we defined exocrine and endocrine 
insufficiency based on the need for pancreatic enzyme 
replacement therapy and antidiabetics/insulin. This en-
tails a risk of underestimating the number of patients with 
these insufficiencies, whereas direct pancreatic function 
testing or measurement of glycated hemoglobin or C-
peptide might have resulted in a more accurate evaluation. 
Thirdly, although various types of plastic stents and SEMS 
were used in this study, we could not identify the benefits 
of each stent type due to small sample size. Moreover, in 
Korea, of the currently available lumen-apposing metal-
lic stents, only SPAXUS stent (Taewoong Medical) can be 
used, so the effectiveness of the 16 mm diameter Hot Axios 
(Boston Scientific) that has been used worldwide17 could 
not been verified. However, the results are considered to 
be meaningful, because incidental SEMS migrations is 
not uncommon during repeated endoscopic retrievals of 
necrotic tissue through the lumen of the SEMS. Finally, no 
standardized follow-up protocol was used for data collec-
tion and there were no objective criteria for visual assess-
ing degree of necrotic debridement in the WON cavity. 
CT scans are an effective method for determining the size 
reduction of WON, so when determining the endpoint of 
DEN, it should be compared with the visual assessment of 
Table 6. The Relationship between WON Recurrence (<6 Months vs ≥6 Months) or Long-term Complications and the Degree of Clearance of Intra-
cavitary Necrotic Tissue at the Last Session of DEN
Degree of clearance of intracavitary necrotic tissue at the end session of DEN
p-valueComplete clearance of intracavitary  
necrotic tissue (n=8)
Incomplete clearance of intracavitary  
necrotic tissue (n=49)
DEN failure of complicated/symptomatic 
WON recurrence within 6 months after 
discharge (yes/no)
0/8   4/45 <0.99
Long-term WON recurrence more than 6 
months after discharge (yes/no)
1/7   2/47 0.37
Long-term complications including newly 
developed DM, pancreatic exocrine 
insufficiency, others (yes/no)*
2/6 12/37 <0.99
WON, walled-off necrosis; DEN, direct endoscopic necrosectomy; DM, diabetes mellitus.
*Others include chylous ascites and recurrent small bowel obstruction.
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necrotic debris in the WON cavity. Unfortunately, no data 
has been collected in this study. 
In conclusion, as a targeted and minimally invasive ap-
proach, DEN is regarded as an efficacious and reproducible 
technique for the treatment of complicated or symptomatic 
WON with an acceptable safety profile. Considering that 
long-term complications are similar to those observed after 
pancreatectomy, DEN should be performed meticulously 
so as to minimize damage to the pancreatic parenchyma 
and should be combined with antibiotics possessing ad-
equate coverage against identified pathogens. Additional 
multicenter prospective studies are needed to validate the 
conclusions of our study. 
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